nested case control study [version 1; referees: 1 approved]

Although nausea and vomiting are very common in pregnancy, Background: their pathogenesis is poorly understood. We tested the hypothesis that circulating growth and differentiation factor 15 (GDF15) concentrations in early pregnancy, whose gene is implicated in hyperemesis gravidarum, are associated with nausea and vomiting. Blood samples for the measurement of GDF15 and human chorionicMethods: gonadotrophin (hCG) concentrations were obtained early in the second trimester (median 15.1 (interquartile range 14.4-15.7) weeks) of pregnancy from 791 women from the Cambridge Baby Growth Study, a prospective pregnancy and birth cohort. During each trimester participants completed a questionnaire which included questions about nausea, vomiting and antiemetic use. Associations with pre-pregnancy body mass indexes (BMI) were validated in 231 pregnant NIPTeR Study participants. Circulating GDF15 concentrations were higher in women reportingResults: vomiting in the second trimester than in women reporting no pregnancy nausea or vomiting: 11,581 (10,977-12,219)(n= 175) vs. 10,593 (10,066-11,147)(n= 193) pg/mL, p= 0.02). In women who took antiemetic drugs during pregnancy (n= 11) the GDF15 levels were also raised 13,157 (10,558-16,394) pg/mL (p= 0.04). Serum GFD15 concentrations were strongly positively correlated with hCG levels but were inversely correlated with maternal BMIs, a finding replicated in the NIPTeR Study. Week 15 serum GDF15 concentrations are positively associatedConclusions: with second trimester vomiting and maternal antiemetic use in pregnancy. Given GDF15’s site of action in …